Wiche Salinas, TR; Zhang, Y; Sarnello, D; Zhyvoloup, A; Marchand, LR; Fert, A; Planas, D; ... Fassati, A; + view all Wiche Salinas, TR; Zhang, Y; Sarnello, D; Zhyvoloup, A; Marchand, LR; Fert, A; Planas, D; Lodha, M; Chatterjee, D; Karwacz, K; Oxenford, S; Routy, J-P; Irlbeck, D; Amrine-Madsen, H; Ancuta, P; Fassati, A; - view fewer (2021) Th17 cell master transcription factor RORC2 regulates HIV-1 gene expression and viral outgrowth. Proceedings of the National Academy of Sciences , 118 (48) , Article e2105927118. 10.1073/pnas.2105927118.

Preview

Text e2105927118.full.pdf - Published Version Download (2MB) | Preview

Abstract

Among CD4+ T cells, T helper 17 (Th17) cells are particularly susceptible to HIV-1 infection and are depleted from mucosal sites, which causes damage to the gut barrier, resulting in a microbial translocation-induced systemic inflammation, a hallmark of disease progression. Furthermore, a proportion of latently infected Th17 cells persist long term in the gastrointestinal lymphatic tract where a low-level HIV-1 transcription is observed. This residual viremia contributes to chronic immune activation. Thus, Th17 cells are key players in HIV pathogenesis and viral persistence. It is, however, unclear why these cells are highly susceptible to HIV-1 infection. Th17 cell differentiation depends on the expression of the master transcriptional regulator RORC2, a retinoic acid-related nuclear hormone receptor that regulates specific transcriptional programs by binding to promoter/enhancer DNA. Here, we report that RORC2 is a key host cofactor for HIV replication in Th17 cells. We found that specific inhibitors that bind to the RORC2 ligand-binding domain reduced HIV replication in CD4+ T cells. The depletion of RORC2 inhibited HIV-1 infection, whereas its overexpression enhanced it. RORC2 was also found to promote HIV-1 gene expression by binding to the nuclear receptor responsive element in the HIV-1 long terminal repeats (LTR). In treated HIV-1 patients, RORC2+ CD4 T cells contained more proviral DNA than RORC2- cells. Pharmacological inhibition of RORC2 potently reduced HIV-1 outgrowth in CD4+ T cells from antiretroviral-treated patients. Altogether, these results provide an explanation as to why Th17 cells are highly susceptible to HIV-1 infection and suggest that RORC2 may be a cell-specific target for HIV-1 therapy.

Download activity - last month

Export as JSONCSVXML

Download activity - last 12 months

Export as JSONCSVXML

Downloads by country - last 12 months

Export as XMLCSVJSON

Archive Staff Only

View Item